Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Coherus
Biotech
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Galapagos CEO eyes exit as spinout names leader. Longtime NIH leader set to retire as chief of staff. Lilly exec jumps to Zealand.
Darren Incorvaia
,
Zoey Becker
Apr 25, 2025 8:30am
Coherus to lose 30% of staff as part of Udenyca sale to Accord
Mar 11, 2025 7:30am
Coherus axes TIGIT program 2 years after making $35M bet
Jan 10, 2024 7:50am
Surface warns bankruptcy possible if shareholders reject merger
Aug 2, 2023 10:00am
Coherus scratches the Surface with $65M buy
Jun 16, 2023 10:45am
Coherus slashes staff by a third after biosimilar knockback
Jun 29, 2017 9:48am